Hutchmed (China) Limited

Net Asset Value • Jul 1, 2013

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1338I

Hutchison China Meditech Limited

01 July 2013

Hutchison China MediTech Limited ("Chi-Med")

(AIM: HCM)

Blocklisting Six Monthly Return

London: Monday, 1 July 2013: Chi-Med announces the following blocklisting six monthly return:

1.	Name of applicant:		Hutchison China MediTech Limited
2.	Name of scheme:		Hutchison China MediTech Limited Share Option Scheme
3.	Period of return:		From 29 December 2012 to 28 June 2013
4.	Balance under scheme from previous return:		1,724,279 ordinary shares of US$1 each
5.	The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return:		Nil
6.	Number of securities issued/allotted under scheme during period:		3,000 ordinary shares of US$1 each
7.	Balance under scheme not yet issued/allotted at end of the period:		1,721,279 ordinary shares of US$1 each
8.	Number and class of securities originally listed and the date of admission:		2,560,606 ordinary shares of US$1 each admitted on 26 June 2007
9.	Total number of securities in issue at the end of the period:		52,051,448 ordinary shares of US$1 each
Name of contact:			Christian Hogg
Address of contact:			21/F., Hutchison House, 10 Harcourt Road, Hong Kong
Telephone number of contact:			+852 2121 8200

Ends

Enquiries

Chi-Med Christian Hogg, CEO	Telephone:      +852 2121 8200
Panmure Gordon (UK) Limited Richard Gray Andrew Potts Grishma Patel	Telephone:      +44 20 7886 2500
Citigate Dewe Rogerson Anthony Carlisle David Dible	Telephone:      +44 20 7638 9571 Mobile:             +44 7973 611 888 Mobile:             +44 7967 566 919

About Chi-Med

Chi-Med is the holding company of a healthcare group based primarily in China and was listed on the Alternative Investment Market of the London Stock Exchange in May 2006.  It is focused on researching, developing, manufacturing and selling pharmaceuticals and health oriented consumer products.

Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.

This information is provided by RNS

The company news service from the London Stock Exchange

END

BLRKMGZVLRVGFZG